Ferozsons Laboratories Limited (PSX:FEROZ)
333.00
+4.84 (1.47%)
At close: Oct 15, 2026
Ferozsons Laboratories Ratios and Metrics
Market cap in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 14,475 | 17,526 | 16,936 | 10,842 | 5,949 | 9,741 | |
Market Cap Growth | -19.11% | 3.48% | 56.22% | 82.25% | -38.93% | -23.78% |
Enterprise Value | 20,021 | 22,892 | 20,885 | 14,520 | 8,216 | 9,133 |
Last Close Price | 333.00 | 403.18 | 385.92 | 244.49 | 134.15 | 215.46 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 14.79 | 17.91 | 21.81 | 15.87 | 21.93 | 13.26 |
Forward PE | - | 9.70 | 9.70 | 9.48 | 9.59 | 9.59 |
PS Ratio | 0.60 | 0.73 | 0.90 | 0.68 | 0.52 | 1.04 |
PB Ratio | 0.93 | 1.12 | 1.17 | 0.92 | 0.71 | 1.17 |
P/TBV Ratio | 1.09 | 1.33 | 1.37 | 0.97 | 0.75 | 1.25 |
P/FCF Ratio | - | - | 21.94 | - | - | - |
P/OCF Ratio | 33.81 | 40.94 | 11.80 | - | - | 32.81 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 0.84 | 0.96 | 1.11 | 0.92 | 0.72 | 0.98 |
EV/EBITDA Ratio | 6.00 | 6.86 | 7.33 | 6.90 | 5.78 | 5.57 |
EV/EBIT Ratio | 8.55 | 9.78 | 10.79 | 9.14 | 8.66 | 7.49 |
EV/FCF Ratio | - | - | 27.06 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.27 | 0.27 | 0.30 | 0.42 | 0.42 | 0.26 |
Debt / EBITDA Ratio | 1.27 | 1.27 | 1.51 | 2.34 | 2.45 | 1.32 |
Debt / FCF Ratio | - | - | 5.56 | - | - | - |
Net Debt / Equity Ratio | 0.21 | 0.21 | 0.13 | 0.33 | 0.28 | -0.03 |
Net Debt / EBITDA Ratio | 0.96 | 0.96 | 0.68 | 1.84 | 1.67 | -0.17 |
Net Debt / FCF Ratio | -4.27 | -4.27 | 2.51 | -3.59 | -0.83 | 0.19 |
Asset Turnover | 0.95 | 0.95 | 0.81 | 0.83 | 0.75 | 0.72 |
Inventory Turnover | 1.68 | 1.68 | 1.85 | 1.85 | 1.72 | 2.01 |
Quick Ratio | 0.51 | 0.51 | 0.74 | 0.62 | 0.46 | 1.19 |
Current Ratio | 1.87 | 1.87 | 1.94 | 1.61 | 1.55 | 2.29 |
Return on Equity (ROE) | 8.17% | 8.17% | 7.01% | 7.49% | 3.56% | 9.76% |
Return on Assets (ROA) | 5.79% | 5.79% | 5.22% | 5.18% | 3.88% | 5.88% |
Return on Invested Capital (ROIC) | 7.53% | 7.94% | 7.15% | 7.97% | 7.23% | 10.90% |
Return on Capital Employed (ROCE) | 12.70% | 12.70% | 10.80% | 10.10% | 8.50% | 11.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 6.76% | 5.58% | 4.58% | 6.30% | 4.56% | 7.54% |
FCF Yield | -5.18% | -4.28% | 4.56% | -9.96% | -48.10% | -14.96% |
Dividend Yield | 1.65% | 1.36% | 1.03% | 1.20% | - | 1.86% |
Payout Ratio | 17.16% | 17.16% | 16.46% | 0.12% | 64.69% | 47.74% |
Total Shareholder Return | 1.65% | 1.36% | 1.03% | 1.20% | - | 1.86% |